Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of Rectum”

543 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 543 results

Not applicableActive Not RecruitingNCT02874885
What this trial is testing

Circulating Tumor Cells in Patients With Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal AdenocarcinomaMetastatic Rectal AdenocarcinomaRectosigmoid Adenocarcinoma+10 more
M.D. Anderson Cancer Center 341
Early research (Phase 1)Study completedNCT00023933
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Recurrent or Persistent Metastatic Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumRecurrent Colon Cancer+3 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT00016250
What this trial is testing

Ro 31-7453 in Treating Patients With Recurrent or Refractory Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT01634685
What this trial is testing

A Phase I Study of Bavituximab, Capecitabine, and Radiation for the Treatment of Rectal Adenocarcinoma

Who this might be right for
Rectal Adenocarcinoma
University of Texas Southwestern Medical Center 15
Testing effectiveness (Phase 2)UnknownNCT00006115
What this trial is testing

Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Not applicableStudy completedNCT03601689
What this trial is testing

Predictive Factors of Disease-free Survival After Complete Pathological Response to Neoadjuvant Radiotherapy in Rectal Adenocarcinoma

Who this might be right for
Rectal Neoplasms
Moroccan Society of Surgery 84
Early research (Phase 1)Ended earlyNCT04044430
What this trial is testing

Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colon AdenocarcinomaMetastatic Colorectal AdenocarcinomaMetastatic Microsatellite Stable Colorectal Carcinoma+25 more
University of California, San Francisco 2
Testing effectiveness (Phase 2)Study completedNCT00019786
What this trial is testing

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

Who this might be right for
Colorectal CancerIslet Cell TumorLiver Cancer+2 more
National Institutes of Health Clinical Center (CC) 67
Not applicableUnknownNCT02196597
What this trial is testing

Value of Anorectal Manometry Before Ileo- or Sigmoidostomy Closure After Rectal Resection

Who this might be right for
Fecal IncontinenceQuality of Life
German Society for Neurogastroenterology and Motility 30
Large-scale testing (Phase 3)Looking for participantsNCT06312982
What this trial is testing

A Series of Neoadjuvant Chemoradiotherapy Combined With Immunotherapy for Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Carcinoma
Beijing Friendship Hospital 375
Testing effectiveness (Phase 2)WithdrawnNCT00070434
What this trial is testing

S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the Rectum

Who this might be right for
Colorectal Cancer
SWOG Cancer Research Network
Testing effectiveness (Phase 2)Study completedNCT00081289
What this trial is testing

Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer

Who this might be right for
Colorectal Cancer
Radiation Therapy Oncology Group 146
Large-scale testing (Phase 3)Study completedNCT00427713
What this trial is testing

Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer

Who this might be right for
Colorectal Cancer
Cancer Research UK 800
Not applicableUnknownNCT02081547
What this trial is testing

IPC Status as a Surgical Quality Marker in Rectal Cancer Surgery

Who this might be right for
Rectal Cancer
Uppsala University 50
Not applicableUnknownNCT04090450
What this trial is testing

Optimisation of Radiotherapy in Rectal Cancer (ORREC)

Who this might be right for
Rectal Adenocarcinoma
University of Manchester 1,500
Testing effectiveness (Phase 2)WithdrawnNCT02575508
What this trial is testing

Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer

Who this might be right for
Colon AdenocarcinomaMetastatic Pancreatic AdenocarcinomaPancreatic Adenocarcinoma+14 more
Roswell Park Cancer Institute
Not applicableActive Not RecruitingNCT04713618
What this trial is testing

Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation Therapy

Who this might be right for
Anal CarcinomaCervical CarcinomaEndometrial Carcinoma+4 more
Ohio State University Comprehensive Cancer Center 89
Large-scale testing (Phase 3)Ended earlyNCT03462563
What this trial is testing

Prospective, Multicenter, Randomized Controlled Study to Evaluate the Effect of INTERCEED™

Who this might be right for
Subjects Scheduled to Undergo Laparoscopic Radical Resection of Rectal Carcinoma With Preventive Ileostomy
Ethicon, Inc. 175
Large-scale testing (Phase 3)Study completedNCT00026273
What this trial is testing

Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal Cancer

Who this might be right for
Colorectal Cancer
Pfizer
Testing effectiveness (Phase 2)Study completedNCT02368886
What this trial is testing

Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer

Who this might be right for
Colon AdenocarcinomaRectal AdenocarcinomaStage III Colorectal Cancer AJCC v7+6 more
Academic and Community Cancer Research United 123
Load More Results